A carregar...

Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells

Lenalidomide is an immunomodulatory drug with therapeutic activity in chronic lymphocytic leukemia (CLL). However, it has pleiotropic effects, and the mechanism of action responsible for its therapeutic activity has not been well defined yet. Herein, we show that lenalidomide treatment does not have...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Acebes-Huerta, Andrea, Huergo-Zapico, Leticia, Gonzalez-Rodriguez, Ana Pilar, Fernandez-Guizan, Azahara, Payer, Angel R., López-Soto, Alejandro, Gonzalez, Segundo
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4182694/
https://ncbi.nlm.nih.gov/pubmed/25313353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/265840
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!